1. Home
  2. WST vs TPL Comparison

WST vs TPL Comparison

Compare WST & TPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TPL
  • Stock Information
  • Founded
  • WST 1923
  • TPL 1888
  • Country
  • WST United States
  • TPL United States
  • Employees
  • WST N/A
  • TPL N/A
  • Industry
  • WST Medical/Dental Instruments
  • TPL Oil & Gas Production
  • Sector
  • WST Health Care
  • TPL Energy
  • Exchange
  • WST Nasdaq
  • TPL Nasdaq
  • Market Cap
  • WST 15.2B
  • TPL 29.1B
  • IPO Year
  • WST N/A
  • TPL N/A
  • Fundamental
  • Price
  • WST $213.06
  • TPL $1,301.28
  • Analyst Decision
  • WST Strong Buy
  • TPL Strong Buy
  • Analyst Count
  • WST 6
  • TPL 1
  • Target Price
  • WST $349.00
  • TPL $917.00
  • AVG Volume (30 Days)
  • WST 977.3K
  • TPL 94.7K
  • Earning Date
  • WST 04-24-2025
  • TPL 05-07-2025
  • Dividend Yield
  • WST 0.39%
  • TPL 0.49%
  • EPS Growth
  • WST N/A
  • TPL 6.27
  • EPS
  • WST 6.37
  • TPL 19.99
  • Revenue
  • WST $2,895,800,000.00
  • TPL $727,664,000.00
  • Revenue This Year
  • WST $1.24
  • TPL $19.48
  • Revenue Next Year
  • WST $6.56
  • TPL $19.76
  • P/E Ratio
  • WST $33.62
  • TPL $64.41
  • Revenue Growth
  • WST N/A
  • TPL 10.36
  • 52 Week Low
  • WST $187.43
  • TPL $578.56
  • 52 Week High
  • WST $372.79
  • TPL $1,769.14
  • Technical
  • Relative Strength Index (RSI)
  • WST 48.76
  • TPL 49.57
  • Support Level
  • WST $204.79
  • TPL $1,268.95
  • Resistance Level
  • WST $221.42
  • TPL $1,379.58
  • Average True Range (ATR)
  • WST 7.01
  • TPL 46.57
  • MACD
  • WST 1.16
  • TPL 0.41
  • Stochastic Oscillator
  • WST 56.77
  • TPL 32.84

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TPL Texas Pacific Land Corporation

Texas Pacific Land Corp is mainly engaged in the sales and leases of land owned, retaining oil and gas royalties, and the overall management of the land owned. It operates its business in two reportable segments; Land and Resource Management and Water Service and Operations. The Land and Resource Management segment focuses on managing surface acres of land and its oil and gas royalty interests, principally concentrated in the Permian Basin. The Water Services and Operations segment encompasses the business of providing full-service water offerings to operators, produced-water treatment, infrastructure development, and disposal solutions. The company generates the majority of its revenue from the Land and Resource Management segment.

Share on Social Networks: